Target intelligence / Profile preview

RNA, U6 small nuclear 576, pseudogene (RNU6-576P)

Target
RNU6-576P
Molecular classification
Other (non-coding RNA pseudogene, not an enzyme, receptor, transcription factor, etc.)
01

Overview

RNU6-576P is a **pseudogene** originating from the U6 small nuclear RNA gene family[2][5][6]. U6 snRNA itself is a highly conserved non-coding RNA component of the spliceosome responsible for the excision of introns from pre-mRNA in the nucleus of eukaryotes[3][1]. However, pseudogenes like RNU6-576P do not encode functional RNA, proteins, or contribute directly to this process. Instead, they result from gene duplication or retrotransposition events and usually contain sequence similarity to the functional parent gene, such as possessing authentic 5’- and 3’-ends or internal repeats but lacking biological activity[5][6]. In genomic studies, RNU6-derived pseudogenes are considered important for understanding genome evolution and retrotransposition dynamics but not as molecular targets for therapy or diagnostics[6]. If you seek a genuine molecular target, reference should be made to the functional U6 snRNA gene (e.g., RNU6-1)[3][1].\n\nThis locus is **not a receptor, enzyme, transporter, transcription factor, or direct therapeutic target**. No drugs interact with it, and it is not used as a biomarker. It is listed here only because of its origin as a U6 snRNA pseudogene, and there is no current evidence for its involvement in human disease or drug response. If your intended query concerns the functional U6 snRNA, that entity has a well-defined role in pre-mRNA splicing[3][1].

Other names
RNU6-576PU6 snRNA pseudogeneU6 small nuclear RNA pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 576, pseudogene (RNU6-576P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 576, pseudogene (RNU6-576P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call